Black box warning to be added for GSK, Roche/Biogen cancer drugs

(Reuters) - U.S. regulators strengthened the warning labels on two cancer drugs - GlaxoSmithKline Plc's Arzerra, and Rituxan, made by Biogen Idec Inc and Roche Holding AG - to reflect the risk that th…
Read the full story: MedCity News